Works by Kagawa, Tatehiro


Results: 73
    1
    2
    3

    Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.

    Published in:
    Oncologist, 2023, v. 28, n. 7, p. e526, doi. 10.1093/oncolo/oyad090
    By:
    • Fukushima, Taito;
    • Morimoto, Manabu;
    • Kobayashi, Satoshi;
    • Ueno, Makoto;
    • Uojima, Haruki;
    • Hidaka, Hisashi;
    • Kusano, Chika;
    • Chuma, Makoto;
    • Numata, Kazushi;
    • Tsuruya, Kota;
    • Arase, Yoshitaka;
    • Kagawa, Tatehiro;
    • Hattori, Nobuhiro;
    • Ikeda, Hiroki;
    • Watanabe, Tsunamasa;
    • Tanaka, Katsuaki;
    • Maeda, Shin
    Publication type:
    Article
    4
    5
    6

    Comparison of Two Interferon Alfa Treatment Regimens Characterized by an Early Virological Response in Patients With Chronic Hepatitis C.

    Published in:
    American Journal of Gastroenterology (Springer Nature), 1998, v. 93, n. 2, p. 192, doi. 10.1111/j.1572-0241.1998.00192.x
    By:
    • Kagawa, Tatehiro;
    • Hosoi, Katsumi;
    • Takashimizu, Shinji;
    • Kawazoe, Kazuya;
    • Mochizuki, Kaori;
    • Wasada, Mitsuru;
    • Nagata, Naruhiko;
    • Uchiyama, Junzo;
    • Nakano, Atsushi;
    • Nishizaki, Yasuhiro;
    • Watanabe, Norihito;
    • Matsuzaki, Shohei
    Publication type:
    Article
    7
    8

    Comparative study of MAFLD as a predictor of metabolic disease treatment for NAFLD.

    Published in:
    Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-64301-3
    By:
    • Imai, Jin;
    • Takashimizu, Shinji;
    • Suzuki, Nana;
    • Ohshinden, Kana;
    • Sawamoto, Kana;
    • Mishima, Yusuke;
    • Tsuruya, Kota;
    • Arase, Yoshitaka;
    • Yamano, Mitsuhiko;
    • Kishimoto, Noriaki;
    • Yamada, Chizumi;
    • Inoue, Nagamu;
    • Moriyama, Kengo;
    • Baba, Akiyasu;
    • Suzuki, Hidekazu;
    • Kagawa, Tatehiro;
    • Nishizaki, Yasuhiro
    Publication type:
    Article
    9
    10
    11
    12
    13

    Comparative study between sorafenib and lenvatinib as the first‐line therapy in the sequential treatment of unresectable hepatocellular carcinoma in a real‐world setting.

    Published in:
    JGH Open, 2022, v. 6, n. 1, p. 29, doi. 10.1002/jgh3.12691
    By:
    • Fukushima, Taito;
    • Morimoto, Manabu;
    • Ueno, Makoto;
    • Kubota, Kousuke;
    • Uojima, Haruki;
    • Hidaka, Hisashi;
    • Chuma, Makoto;
    • Numata, Kazushi;
    • Tsuruya, Kota;
    • Hirose, Shunji;
    • Kagawa, Tatehiro;
    • Hattori, Nobuhiro;
    • Watanabe, Tsunamasa;
    • Matsunaga, Kotaro;
    • Yamamoto, Kouji;
    • Tanaka, Katsuaki;
    • Maeda, Shin
    Publication type:
    Article
    14
    15

    Plasma Lipid Profiling of Three Types of Drug-Induced Liver Injury in Japanese Patients: A Preliminary Study.

    Published in:
    Metabolites (2218-1989), 2020, v. 10, n. 9, p. 355, doi. 10.3390/metabo10090355
    By:
    • Saito, Kosuke;
    • Kagawa, Tatehiro;
    • Tsuji, Keiji;
    • Kumagai, Yuji;
    • Sato, Ken;
    • Sakisaka, Shotaro;
    • Sakamoto, Naoya;
    • Aiso, Mitsuhiko;
    • Hirose, Shunji;
    • Mori, Nami;
    • Tanaka, Rieko;
    • Uraoka, Toshio;
    • Takata, Kazuhide;
    • Ogawa, Koji;
    • Mori, Kazuhiko;
    • Sato, Motonobu;
    • Nishiya, Takayoshi;
    • Takamatsu, Kazuhiko;
    • Arakawa, Noriaki;
    • Izumi, Takashi
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23

    Esophageal Varices as an Independent Predictor of Fatal Outcomes after Balloon-Occluded Retrograde Transvenous Obliteration in Patients with Hepatic Encephalopathy.

    Published in:
    Digestive Diseases, 2024, v. 42, n. 6, p. 583, doi. 10.1159/000541660
    By:
    • Iwasaki, Shuichiro;
    • Uojima, Haruki;
    • Sakita, Shinya;
    • Masuda, Sakue;
    • Kubota, Kousuke;
    • Fujikawa, Tomoaki;
    • Okubo, Tomomi;
    • Setsu, Toru;
    • Itokawa, Norio;
    • Furuichi, Yoshihiro;
    • Arase, Yoshitaka;
    • Tukiyama, Toshiki;
    • Fujii, Kaoru;
    • Hidaka, Hisashi;
    • Atsukawa, Masanori;
    • Kagawa, Tatehiro;
    • Kako, Makoto;
    • Terai, Shuji;
    • Kusano, Chika
    Publication type:
    Article
    24

    The Risk of Cirrhosis and Its Complications Based on PNPLA3 rs738409 G Allele Frequency.

    Published in:
    Digestive Diseases, 2022, v. 40, n. 5, p. 625, doi. 10.1159/000521062
    By:
    • Shao, Xue;
    • Uojima, Haruki;
    • Arai, Taeang;
    • Ogawa, Yuji;
    • Setsu, Toru;
    • Atsukawa, Masanori;
    • Furuichi, Yoshihiro;
    • Arase, Yoshitaka;
    • Horio, Kazue;
    • Hidaka, Hisashi;
    • Nakazawa, Takahide;
    • Kako, Makoto;
    • Kagawa, Tatehiro;
    • Iwakiri, Katsuhiko;
    • Nakajima, Atsushi;
    • Terai, Shuji;
    • Tanaka, Yasuhito;
    • Koizumi, Wasaburo
    Publication type:
    Article
    25
    26

    Impact of Anti-GPIIb/IIIa Antibody-Producing B Cells as a Predictor of the Response to Lusutrombopag in Thrombocytopenic Patients with Liver Disease.

    Published in:
    Digestive Diseases, 2021, v. 39, n. 3, p. 234, doi. 10.1159/000510692
    By:
    • Wada, Naohisa;
    • Uojima, Haruki;
    • Satoh, Takashi;
    • Okina, Sosei;
    • Iwasaki, Shuichiro;
    • Shao, Xue;
    • Takiguchi, Hayato;
    • Arase, Yoshitaka;
    • Itokawa, Norio;
    • Atsukawa, Masanori;
    • Miyazaki, Koji;
    • Hidaka, Hisashi;
    • Kako, Makoto;
    • Kagawa, Tatehiro;
    • Iwakiri, Katsuhiko;
    • Horie, Ryouichi;
    • Suzuki, Takahiro;
    • Koizumi, Wasaburo
    Publication type:
    Article
    27
    28
    29
    30

    Eight-week oral administration of meloxicam, a non-steroidal anti-inflammatory drug, prevents dose reduction of pegylated interferon α-2a in the treatment of chronic hepatitis C.

    Published in:
    Hepatology Research, 2008, v. 38, n. 3, p. 259, doi. 10.1111/j.1872-034X.2007.00260.x
    By:
    • Kagawa, Tatehiro;
    • Shiozawa, Hirokazu;
    • Kojima, Sei-ichiro;
    • Takashimizu, Shinji;
    • Nagata, Naruhiko;
    • Numata, Makoto;
    • Morino, Fumitoshi;
    • Nishizaki, Yasuhiro;
    • Mochizuki, Kaori;
    • Watanabe, Norihito;
    • Watanabe, Tetsu;
    • Matsuzaki, Shohei;
    • Mine, Tetsuya
    Publication type:
    Article
    31
    32

    Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy.

    Published in:
    2018
    By:
    • Matsumoto, Akihiro;
    • Nishiguchi, Shuhei;
    • Enomoto, Hirayuki;
    • Kang, Jong-Hon;
    • Tanaka, Yasuhito;
    • Shinkai, Noboru;
    • Kurosaki, Masayuki;
    • Enomoto, Masaru;
    • Kanda, Tatsuo;
    • Yokosuka, Osamu;
    • Yatsuhashi, Hiroshi;
    • Nagaoka, Shinya;
    • Okuse, Chiaki;
    • Kagawa, Tatehiro;
    • Mine, Tetsuya;
    • Takaguchi, Koichi;
    • Saito, Satoru;
    • Hino, Keisuke;
    • Ikeda, Fusao;
    • Sakisaka, Shotaro
    Publication type:
    journal article
    33

    Differential Impact of Adherence to Pegylated Interferon and Ribavirin in the Treatment of Genotype 1 High Viral Titer Chronic Hepatitis C.

    Published in:
    Hepatitis Research & Treatment, 2010, p. 1, doi. 10.1155/2010/702748
    By:
    • Numata, Makoto;
    • Kagawa, Tatehiro;
    • Kojima, Sei-ichiro;
    • Hirose, Shunji;
    • Nagata, Naruhiko;
    • Shiraishi, Koichi;
    • Watanabe, Norihito;
    • Shiozawa, Hirokazu;
    • Nishizaki, Yasuhiro;
    • Motegi, Shigeyuki;
    • Takashimizu, Shinji;
    • Kamochi, Jun-ichiro;
    • Wasada, Mitsuru;
    • Ohno, Takashi;
    • Tei, Yoshihiro;
    • Nakano, Atsushi;
    • Yamada, Takuji;
    • Atsukawa, Kazuhiro;
    • Watanabe, Tetsu;
    • Mine, Tetsuya
    Publication type:
    Article
    34
    35
    36
    37

    Progression pattern and post‐progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma.

    Published in:
    Liver International, 2024, v. 44, n. 6, p. 1343, doi. 10.1111/liv.15825
    By:
    • Kobayashi, Satoshi;
    • Fukushima, Taito;
    • Ueno, Makoto;
    • Chuma, Makoto;
    • Numata, Kazushi;
    • Tsuruya, Kota;
    • Arase, Yoshitaka;
    • Hirose, Shunji;
    • Kagawa, Tatehiro;
    • Hattori, Nobuhiro;
    • Watanabe, Tsunamasa;
    • Matsunaga, Kotaro;
    • Uojima, Haruki;
    • Hidaka, Hisashi;
    • Kusano, Chika;
    • Morimoto, Manabu;
    • Maeda, Shin
    Publication type:
    Article
    38
    39
    40

    Evaluation of the associations of interlukin‐7 genetic variants with toxicity and efficacy of immune checkpoint inhibitors: A replication study of a Japanese population, based on the findings of a European genome‐wide association study.

    Published in:
    Hepatology Research, 2024, v. 54, n. 12, p. 1215, doi. 10.1111/hepr.14092
    By:
    • Miyamoto, Hideaki;
    • Kondo, Yasuteru;
    • Itobayashi, Ei;
    • Uehara, Masayoshi;
    • Hiraoka, Atsushi;
    • Kudo, Masatoshi;
    • Kakizaki, Satoru;
    • Kagawa, Tatehiro;
    • Miuma, Satoshi;
    • Suzuki, Takanori;
    • Sugi, Kazuhiro;
    • Suyama, Koichi;
    • Beppu, Toru;
    • Toyoda, Hidenori;
    • Yoshiji, Hitoshi;
    • Uojima, Haruki;
    • Miyase, Shiho;
    • Inoue, Kaori;
    • Tamori, Akihiro;
    • Ito, Takanori
    Publication type:
    Article
    41

    Lenvatinib radiofrequency ablation sequential therapy offers survival benefits for patients with unresectable hepatocellular carcinoma at intermediate stage and the liver reserve of Child–Pugh A category: A multicenter study.

    Published in:
    Hepatology Research, 2024, v. 54, n. 12, p. 1174, doi. 10.1111/hepr.14089
    By:
    • Zhang, Ying;
    • Numata, Kazushi;
    • Imajo, Kento;
    • Uojima, Haruki;
    • Funaoka, Akihiro;
    • Komiyama, Satoshi;
    • Ogushi, Katsuaki;
    • Chuma, Makoto;
    • Irie, Kuniyasu;
    • Kokubu, Shigehiro;
    • Yoneda, Masato;
    • Kobayashi, Takashi;
    • Hidaka, Hisashi;
    • Fukushima, Taito;
    • Kobayashi, Satoshi;
    • Morimoto, Manabu;
    • Kagawa, Tatehiro;
    • Hattori, Nobuhiro;
    • Watanabe, Tsunamasa;
    • Iwase, Shigeru
    Publication type:
    Article
    42

    RECAM‐J 2023—Validation and development of the Japanese version of RECAM for the diagnosis of drug‐induced liver injury.

    Published in:
    Hepatology Research, 2024, v. 54, n. 6, p. 503, doi. 10.1111/hepr.14046
    By:
    • Tanaka, Atsushi;
    • Tsuji, Keiji;
    • Komiyama, Yasuyuki;
    • Tsuruya, Kota;
    • Kakisaka, Keisuke;
    • Tsutsui, Akemi;
    • Ichimoto, Keiko;
    • Ueno, Masayuki;
    • Okazaki, Yuki;
    • Kamimura, Hiroteru;
    • Takai, Atsushi;
    • Yamashiki, Noriyo;
    • Ito, Takanori;
    • Watanabe, Masaaki;
    • Abe, Masanori;
    • Harada, Ken‐ichi;
    • Kagawa, Tatehiro
    Publication type:
    Article
    43

    Significant association between HLA‐B*35:01 and onset of drug‐induced liver injury caused by Kampo medicines in Japanese patients.

    Published in:
    Hepatology Research, 2023, v. 53, n. 5, p. 440, doi. 10.1111/hepr.13874
    By:
    • Nakamura, Ryosuke;
    • Arakawa, Noriaki;
    • Tanaka, Yoichi;
    • Uchiyama, Nahoko;
    • Sekine, Akihiro;
    • Mashimo, Yoichi;
    • Tsuji, Keiji;
    • Kagawa, Tatehiro;
    • Sato, Ken;
    • Watanabe, Masaaki;
    • Aiso, Mitsuhiko;
    • Hiasa, Yoichi;
    • Takei, Yoshiyuki;
    • Ohira, Hiromasa;
    • Ayada, Minoru;
    • Tsukagoshi, Eri;
    • Maekawa, Keiko;
    • Tohkin, Masahiro;
    • Saito, Yoshiro;
    • Takikawa, Hajime
    Publication type:
    Article
    44

    Cell‐free and concentrated ascites reinfusion therapy versus large‐volume paracentesis for the treatment of cirrhotic patients with refractory ascites: A multicenter prospective observational study.

    Published in:
    Hepatology Research, 2023, v. 53, n. 3, p. 238, doi. 10.1111/hepr.13860
    By:
    • Hanai, Tatsunori;
    • Kawaratani, Hideto;
    • Nagano, Junji;
    • Suii, Hirokazu;
    • Sakamaki, Akira;
    • Arase, Yoshitaka;
    • Nakanishi, Hiroyuki;
    • Kogiso, Tomomi;
    • Okubo, Tomomi;
    • Miwa, Takao;
    • Shimizu, Shogo;
    • Hige, Shuhei;
    • Atsukawa, Masanori;
    • Shimizu, Masahito;
    • Kurosaki, Masayuki;
    • Terai, Shuji;
    • Kagawa, Tatehiro;
    • Tokushige, Katsutoshi;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    45

    Frequency of null genotypes of glutathione S‐transferase M1 and T1 in Japanese patients with drug‐induced liver injury.

    Published in:
    Hepatology Research, 2022, v. 52, n. 10, p. 882, doi. 10.1111/hepr.13812
    By:
    • Maeda, Kazuya;
    • Takikawa, Hajime;
    • Aiso, Mitsuhiko;
    • Tsuji, Kenji;
    • Kagawa, Tatehiro;
    • Watanabe, Masaaki;
    • Sato, Ken;
    • Sakisaka, Shotaro;
    • Hiasa, Yoichi;
    • Takei, Yoshiyuki;
    • Ohira, Hiromasa;
    • Hashimoto, Etsuko;
    • Ayada, Minoru;
    • Ikegami, Tadashi;
    • Arakawa, Noriaki;
    • Kusuhara, Hiroyuki;
    • Saito, Yoshiro;
    • Sugiyama, Yuichi
    Publication type:
    Article
    46
    47
    48

    Analysis of 307 cases with drug‐induced liver injury between 2010 and 2018 in Japan.

    Published in:
    Hepatology Research, 2019, v. 49, n. 1, p. 105, doi. 10.1111/hepr.13288
    By:
    • Aiso, Mitsuhiko;
    • Takikawa, Hajime;
    • Tsuji, Keiji;
    • Kagawa, Tatehiro;
    • Watanabe, Masaaki;
    • Tanaka, Atsushi;
    • Sato, Ken;
    • Sakisaka, Shotaro;
    • Hiasa, Yoichi;
    • Takei, Yoshiyuki;
    • Ohira, Hiromasa;
    • Ayada, Minoru;
    • Hashimoto, Etsuko;
    • Kaneko, Shuichi;
    • Ueno, Yoshiyuki;
    • Ohmoto, Kenji;
    • Takaki, Akinobu;
    • Torimura, Takuji;
    • Matsuzaki, Yasushi;
    • Tajiri, Kazuto
    Publication type:
    Article
    49
    50

    Meloxicam as an adjuvant to peginterferon-α-2a and ribavirin treatment for genotype 1 chronic hepatitis C: A randomized trial.

    Published in:
    Hepatology Research, 2013, v. 43, n. 9, p. 925, doi. 10.1111/hepr.12046
    By:
    • Kagawa, Tatehiro;
    • Kojima, Sei‐ichiro;
    • Shiraishi, Koichi;
    • Hirose, Shunji;
    • Arase, Yoshitaka;
    • Takashimizu, Shinji;
    • Watanabe, Norihito;
    • Nagata, Naruhiko;
    • Numata, Makoto;
    • Shiozawa, Hirokazu;
    • Nishizaki, Yasuhiro;
    • Toki, Mayu;
    • Sugita, Teruji;
    • Nomura, Kijuro;
    • Sakaguchi, Takashi;
    • Atsukawa, Kazuhiro;
    • Tajima, Hiroto;
    • Tei, Yoshihiro;
    • Inomoto, Tsutomu;
    • Mine, Tetsuya
    Publication type:
    Article